Marinus Verwijs, CHIEF TECHNOLOGY OFFICER at Aerovate Therapeutics, Inc. (AVTE), sold 970 shares at $10.46 ($10K) on 2023-11-01, disclosed to the SEC on 2023-11-03.
Open-market sale of $10k AVTE by CHIEF TECHNOLOGY OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AVTE | SELL | 2024-04-03 | $264K | — | Filing → |
| AVTE | SELL | 2024-03-20 | $277K | — | Filing → |
| AVTE | SELL | 2023-05-05 | $16K | — | Filing → |